Empowering women with real-time, personalised information to manage their own menopause transition

Share your experience

About EndoSense

We’re building tools that put knowledge and control in women’s hands—helping each person navigate menopause with clarity, confidence, and care.

Perimenopause

1 in 6
women seeking menopause care have thoughts of self-harm or suicidal ideation
Newson Research
4 years
average length of perimenopause
25%
of women on the highest licensed dose still had subtherapeutic hormone levels on testing
Menopause, The Journal of the Menopause Society
Graph showing hormone levels are more variable during perimenopause with peaks 2–3x higher

Why continuous data matters

Knowing hormone levels in real time enables dynamic dosing of HRT to smooth out short‑term fluctuations, aligning treatment to how you actually feel day to day.

  • Reduce time spent on trial‑and‑error dose changes
  • Lower avoidable side effects by adjusting earlier
  • Support diagnostic decisions with objective trends

Aggregated, privacy‑preserving data can accelerate research—for example, exploring whether the estrogen‑to‑progesterone ratio affects long‑term endometrial cancer risk.

Why single blood tests fall short: Hormone levels can swing widely from day to day during perimenopause. A one‑off blood draw is a snapshot that often misses the true pattern—trends over time are what matter.

Technology

Exploded view of EndoSense CHM with reusable electronics, wireless rechargeable battery, NFC/BLE module, and a disposable cartridge with CGM-style filament

The EndoSense continuous hormone monitor (CHM) uses a robust recognition technology, capable of being regenerated by a small electrical current. This overcomes challenges with stability, regeneration and individual calibration that aptamer-based technologies face.

We're proud to be supported by:

  • DSV logo